HOUSTON--(BUSINESS WIRE)--March 23, 2006--GE Healthcare, a unit of General Electric Company (NYSE:GE), and CytoGenix, Inc. (OTCBB:CYGX) have entered into a supply agreement in which GE Healthcare will provide CytoGenix with DNA production reagents for use in the manufacture of vaccines and therapeutic compounds by CytoGenix.
